216 related articles for article (PubMed ID: 36468984)
1. In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
Ten Hacken E; Sewastianik T; Yin S; Hoffmann GB; Gruber M; Clement K; Penter L; Redd RA; Ruthen N; Hergalant S; Sholokhova A; Fell G; Parry EM; Broséus J; Guieze R; Lucas F; Hernández-Sánchez M; Baranowski K; Southard J; Joyal H; Billington L; Regis FFD; Witten E; Uduman M; Knisbacher BA; Li S; Lyu H; Vaisitti T; Deaglio S; Inghirami G; Feugier P; Stilgenbauer S; Tausch E; Davids MS; Getz G; Livak KJ; Bozic I; Neuberg DS; Carrasco RD; Wu CJ
Blood Cancer Discov; 2023 Mar; 4(2):150-169. PubMed ID: 36468984
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
[TBL] [Abstract][Full Text] [Related]
3. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
4. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
5. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Richter syndrome in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Curr Hematol Malig Rep; 2014 Sep; 9(3):294-9. PubMed ID: 25218362
[TBL] [Abstract][Full Text] [Related]
8. Richter transformation with c-MYC overexpression: report of three cases.
Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
[TBL] [Abstract][Full Text] [Related]
9. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
10. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
11. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.
Chigrinova E; Rinaldi A; Kwee I; Rossi D; Rancoita PM; Strefford JC; Oscier D; Stamatopoulos K; Papadaki T; Berger F; Young KH; Murray F; Rosenquist R; Greiner TC; Chan WC; Orlandi EM; Lucioni M; Marasca R; Inghirami G; Ladetto M; Forconi F; Cogliatti S; Votavova H; Swerdlow SH; Stilgenbauer S; Piris MA; Matolcsy A; Spagnolo D; Nikitin E; Zamò A; Gattei V; Bhagat G; Ott G; Zucca E; Gaidano G; Bertoni F
Blood; 2013 Oct; 122(15):2673-82. PubMed ID: 24004666
[TBL] [Abstract][Full Text] [Related]
12. Richter syndrome: biology, incidence, and therapeutic strategies.
Tsimberidou AM; Keating MJ
Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
[TBL] [Abstract][Full Text] [Related]
13. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
Fabbri G; Khiabanian H; Holmes AB; Wang J; Messina M; Mullighan CG; Pasqualucci L; Rabadan R; Dalla-Favera R
J Exp Med; 2013 Oct; 210(11):2273-88. PubMed ID: 24127483
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
[TBL] [Abstract][Full Text] [Related]
15. [Richter Syndrome: Diagnostic and Therapeutic Management].
Croizier C; Guièze R
Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
[TBL] [Abstract][Full Text] [Related]
16. Richter syndrome in B-cell chronic lymphocytic leukemia.
Nakamura N; Abe M
Pathol Int; 2003 Apr; 53(4):195-203. PubMed ID: 12675762
[TBL] [Abstract][Full Text] [Related]
17. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
[TBL] [Abstract][Full Text] [Related]
18. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
Broséus J; Hergalant S; Vogt J; Tausch E; Kreuz M; Mottok A; Schneider C; Dartigeas C; Roos-Weil D; Quinquenel A; Moulin C; Ott G; Blanchet O; Tomowiak C; Lazarian G; Rouyer P; Chteinberg E; Bernhart SH; Tournilhac O; Gauchotte G; Lomazzi S; Chapiro E; Nguyen-Khac F; Chery C; Davi F; Hunault M; Houlgatte R; Rosenwald A; Delmer A; Meyre D; Béné MC; Thieblemont C; Lichter P; Ammerpohl O; Guéant JL; ; Guièze R; Martin-Subero JI; Cymbalista F; Feugier P; Siebert R; Stilgenbauer S
Nat Commun; 2023 Jan; 14(1):309. PubMed ID: 36658118
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
Hess B; Kalmuk J; Znoyko I; Schandl CA; Wagner-Johnston N; Mazzoni S; Hendrickson L; Chiad Z; Greenwell IB; Wolff DJ
Cancer Genet; 2022 Jan; 260-261():18-22. PubMed ID: 34808593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
